Truncated BRPF1 Cooperates with Smoothened to Promote Adult Shh Medulloblastoma

Truncated BRPF1 Cooperates with Smoothened to Promote Adult Shh Medulloblastoma

Summary: The transition of neural progenitors to differentiated postmitotic neurons is mainly considered irreversible in physiological conditions. In the present work, we show that Shh pathway activation through SmoM2 expression promotes postmitotic neurons dedifferentiation, re-entering in the cell...

Full description

Bibliographic Details
Main Authors:	Giuseppe Aiello, Claudio Ballabio, Riccardo Ruggeri, Luca Fagnocchi, Marica Anderle, Ilaria Morassut, Davide Caron, Francesca Garilli, Francesca Gianno, Felice Giangaspero, Silvano Piazza, Alessandro Romanel, Alessio Zippo, Luca Tiberi
Format:	Article
Language:	English
Published:	Elsevier 2019-12-01
Series:	Cell Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211124719315281

Similar Items

Modeling medulloblastoma in vivo and with human cerebellar organoids
by: Claudio Ballabio, et al.
Published: (2020-01-01)

The transcriptional landscape of Shh medulloblastoma
by: Patryk Skowron, et al.
Published: (2021-03-01)

Developmental basis of SHH medulloblastoma heterogeneity
by: Maxwell P. Gold, et al.
Published: (2024-01-01)

Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas
by: Otília Menyhárt, et al.
Published: (2019-03-01)

Comparative analysis of pediatric SHH medulloblastoma DAOY spheres and adherent monolayers: implications for medulloblastoma research
by: Jana Klementová, et al.
Published: (2025-01-01)

Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma
by: Miriam Caimano, et al.
Published: (2021-06-01)

Principles of tumorigenesis and emerging molecular drivers of SHH‐activated medulloblastomas
by: Otília Menyhárt, et al.
Published: (2019-05-01)

Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.
by: Kirti Kandhwal Chahal, et al.
Published: (2019-01-01)

M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas
by: Chanhee Lee, et al.
Published: (2018-05-01)

Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors
by: Rachel M. Moss, et al.
Published: (2023-03-01)

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
by: Mai T. Dang, et al.
Published: (2023-06-01)

Differential Expression of Mitochondrial Biogenesis Markers in Mouse and Human SHH-Subtype Medulloblastoma
by: Maria Łastowska, et al.
Published: (2019-03-01)

Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality
by: Mai T. Dang, et al.
Published: (2021-03-01)

Integration of Signaling Pathways with the Epigenetic Machinery in the Maintenance of Stem Cells
by: Luca Fagnocchi, et al.
Published: (2016-01-01)

Tumorigenic Cell Reprogramming and Cancer Plasticity: Interplay between Signaling, Microenvironment, and Epigenetics
by: Vittoria Poli, et al.
Published: (2018-01-01)

Correction: Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy
Published: (2014-01-01)

Correction: Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy
Published: (2014-01-01)

Correction: Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy.
Published: (2014-01-01)

Correction: Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy.
Published: (2014-01-01)

Integrated computational analyses reveal novel insights into the stromal microenvironment of SHH-subtype medulloblastoma
by: Alexander P. Landry, et al.
Published: (2021-10-01)

mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma
by: Valentina Conti, et al.
Published: (2021-12-01)

Aberrant FGF signaling promotes granule neuron precursor expansion in SHH subgroup infantile medulloblastoma
by: Odessa R Yabut, et al.
Published: (2025-01-01)

REST-dependent downregulation of von Hippel-Lindau tumor suppressor promotes autophagy in SHH-medulloblastoma
by: Ashutosh Singh, et al.
Published: (2024-06-01)

Clinicopathological Characteristics of non-WNT/non-SHH Medulloblastoma Cases in a Pediatric Egyptian Cohort
by: Soheir M. Hamam, et al.
Published: (2023-02-01)

AMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-κB activation
by: Jing Cai, et al.
Published: (2023-01-01)

Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression
by: Stephanie Borlase, et al.
Published: (2023-09-01)

SHH medulloblastoma and very early onset of bowel polyps in a child with PTEN hamartoma tumor syndrome
by: Anna Maria Caroleo, et al.
Published: (2023-08-01)

Smurf1 and Smurf2 mediated polyubiquitination and degradation of RNF220 suppresses Shh-group medulloblastoma
by: Yuwei Li, et al.
Published: (2023-08-01)

Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
by: Jamie Zagozewski, et al.
Published: (2022-07-01)

Spatio-temporal transcriptomics of chromothriptic SHH-medulloblastoma identifies multiple genetic clones that resist treatment and drive relapse
by: Kats, I, et al.
Published: (2024)

Spatio-temporal transcriptomics of chromothriptic SHH-medulloblastoma identifies multiple genetic clones that resist treatment and drive relapse
by: Ilia Kats, et al.
Published: (2024-11-01)

scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
by: Jennifer Ocasio, et al.
Published: (2019-12-01)

3D spheroid models of paediatric SHH medulloblastoma mimic tumour biology, drug response and metastatic dissemination
by: Sophie J. Roper, et al.
Published: (2021-02-01)

STAT3 is required for Smo‐dependent signaling and mediates Smo‐targeted treatment resistance and tumorigenesis in Shh medulloblastoma
by: Liangping Yuan, et al.
Published: (2022-02-01)

Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma
by: Huangyi Fang, et al.
Published: (2023-08-01)

Targeting H3K27me3 demethylase to inhibit Shh signaling and cholesterol metabolism in medulloblastoma growth
by: Hongshi Deng, et al.
Published: (2022-12-01)

PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
by: Alok R Singh, et al.
Published: (2016-01-01)

Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma
by: Seçkin Akgül, et al.
Published: (2018-07-01)

Embryonal tumors in the WHO CNS5 classification: A Review
by: Francesca Gianno, et al.
Published: (2022-01-01)

Chronic AMPK inactivation slows SHH medulloblastoma progression by inhibiting mTORC1 signaling and depleting tumor stem cells
by: Daniel Shiloh Malawsky, et al.
Published: (2023-12-01)